US Patent Issued to Memorial Sloan Kettering Cancer Center on Feb. 17 for "Agents and methods for treating CBP-dependent cancers" (New York Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,847, issued on Feb. 17, was assigned to Memorial Sloan Kettering Cancer Center (New York).

"Agents and methods for treating CBP-dependent cancers" was invented by Alex Kentsis (New York), Kavitha Ramaswamy (New York) and Lauren Marek (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Single chain peptides comprising either a cell penetrating HIV-TAT peptide sequence and a MYB:CBP complex interfering peptide sequence from MYB, or comprising a cell penetrating HIV-TAT peptide sequence, a CBP binding peptide sequence from CREB and a MYB:CBP complex interfering peptide sequence from MYB, are provided for use in preventing MYB:CBP complex formation...